Contact
searchSearch
HMP Global

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Talking Therapeutics

Douglass Jennings
Talking Therapeutics
Signal for Cardiovascular Harm With Triple Inhaler Therapy
03/01/2024
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In this installment of Talking Therapeutics, Dr Jennings reviews cardiovascular harm with triple inhaler therapy for patients with chronic obstructive pulmonary disorder (COPD).
In this installment of Talking Therapeutics, Dr Jennings reviews cardiovascular harm with triple inhaler therapy for patients with chronic obstructive pulmonary disorder (COPD).
In this installment of Talking...
03/01/2024
Pharmacy Learning Network
Jennings Headshot
Talking Therapeutics
Health Benefits of Plant-Based Diets
02/09/2024
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In this installment of Talking Therapeutics, Dr Jennings explores the cardiovascular advantages associated with plant-based diets. He delves into research findings supporting this assertion and shares practical recommendations for patients...
In this installment of Talking Therapeutics, Dr Jennings explores the cardiovascular advantages associated with plant-based diets. He delves into research findings supporting this assertion and shares practical recommendations for patients...
In this installment of Talking...
02/09/2024
Pharmacy Learning Network
Jennings Headshot
Talking Therapeutics
Quad Therapy for Chronic Kidney Disease is on the Horizon
02/09/2024
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In this week’s installment of Talking Therapeutics, Dr Jennings reviews a new study addressing risk reduction in chronic kidney disease with the use of quad therapy.
In this week’s installment of Talking Therapeutics, Dr Jennings reviews a new study addressing risk reduction in chronic kidney disease with the use of quad therapy.
In this week’s installment of...
02/09/2024
Pharmacy Learning Network
Talking Therapeutics
Is Medical Cannabis Hard on the Heart?
02/05/2024
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In this installment of Talking Therapeutics, Dr Jennings discusses a new study that aimed to address this gap in the literature concerning the cardiovascular safety of medical cannabis use.
In this installment of Talking Therapeutics, Dr Jennings discusses a new study that aimed to address this gap in the literature concerning the cardiovascular safety of medical cannabis use.
In this installment of Talking...
02/05/2024
Pharmacy Learning Network
Jennings Headshot
Talking Therapeutics
Combining Nitrates With PDE5 Inhibitors for Patients With Cardiovascular Diseases Is Still a Risk
01/19/2024
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In this installment of Talking Therapeutics, Dr Jennings discusses the complications and risks associated with combining nitrates and PDE5 inhibitors to treat patients with cardiovascular diseases.
In this installment of Talking Therapeutics, Dr Jennings discusses the complications and risks associated with combining nitrates and PDE5 inhibitors to treat patients with cardiovascular diseases.
In this installment of Talking...
01/19/2024
Pharmacy Learning Network
Jennings Headshot
Talking Therapeutics
Dissecting the New 2023 AFib Guidelines
01/10/2024
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In this installment of Talking Therapeutics, Douglas Jennings highlights some of the more significant recommendations from the new 2023 atrial fibrillation treatment guidelines released by the American College of Cardiology and American Heart...
In this installment of Talking Therapeutics, Douglas Jennings highlights some of the more significant recommendations from the new 2023 atrial fibrillation treatment guidelines released by the American College of Cardiology and American Heart...
In this installment of Talking...
01/10/2024
Pharmacy Learning Network
Jennings Headshot
Talking Therapeutics
Changing Treatment Pace for Heart Failure: Why We Shouldn’t Delay Guideline-Directed Medical Therapies
01/02/2024
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In the latest installment of Talking Therapeutics, Dr Jennings explores research that redefines the way health care professionals should approach treatment for patients with heart failure.
In the latest installment of Talking Therapeutics, Dr Jennings explores research that redefines the way health care professionals should approach treatment for patients with heart failure.
In the latest installment of...
01/02/2024
Pharmacy Learning Network
Jennings Headshot
Talking Therapeutics
Can Statins Protect Against the Harms of Hormone Replacement Therapy?
12/21/2023
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In this week's installment of Talking Therapeutics, Dr Jennings explores a new study that addresses hormone replacement therapy and what some health experts may not know about its side effects.
In this week's installment of Talking Therapeutics, Dr Jennings explores a new study that addresses hormone replacement therapy and what some health experts may not know about its side effects.
In this week's installment of...
12/21/2023
Pharmacy Learning Network
Talking Therapeutics
Revealing the Silent Threat: Cardiovascular Disease in Young Adults and the Pursuit of Preventive Measures Through the PRECAD Study
12/11/2023
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In this week’s installment of Talking Therapeutics, Dr Jennings discusses how cardiovascular disease can affect younger patients and how health care professionals can take the initiative to reach a diagnosis.
In this week’s installment of Talking Therapeutics, Dr Jennings discusses how cardiovascular disease can affect younger patients and how health care professionals can take the initiative to reach a diagnosis.
In this week’s installment of...
12/11/2023
Pharmacy Learning Network
Talking Therapeutics
Time to Discontinue Levothyroxine for Heart Organ Donors
12/04/2023
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In this week’s installment of Talking Therapeutics, Dr Jennings evaluates a recent randomized trial to address how hormone deficiency can lead to myocardial energy depletion and subsequent decline in cardiac function in donor recipients.
In this week’s installment of Talking Therapeutics, Dr Jennings evaluates a recent randomized trial to address how hormone deficiency can lead to myocardial energy depletion and subsequent decline in cardiac function in donor recipients.
In this week’s installment of...
12/04/2023
Pharmacy Learning Network

Meet the Author

Dr Jennings is currently an Associate Professor of Pharmacy at Long Island University and the clinical pharmacist for the Heart Transplant and LVAD teams at New York- Presbyterian Hospital Columbia University Irving Medical Center.
He is an active researcher in his field, and he has published over 120 peer-reviewed abstracts and manuscripts, primarily focusing on the pharmacotherapy of patients under mechanical circulatory support.
As a recognized expert in this area, he has been invited to speak at numerous national and international venues, including meetings in France, Saudia Arabia, and India.
Finally, Dr Jennings has been active in professional organizations throughout his career. He is a fellow of the American College of Clinical Pharmacy, the American College of Cardiology, the Heart Failure Society of America, and the AHA.

Advertisement

Additional Insights

Identifying the Important Role Pharmacists Play Among Patients Delaying PCP Care During the Pandemic
Videos
Identifying the Important Role Pharmacists Play Among Patients Delaying PCP Care During the Pandemic
11/10/2020
Andrea Russo, MD, director, Electrophysiology and Arrhythmia Services, Cooper Hospital, discusses why there have been delays among patients making primary care visits, along with the impact this has on diagnosis, and she provides tips for...
Andrea Russo, MD, director, Electrophysiology and Arrhythmia Services, Cooper Hospital, discusses why there have been delays among patients making primary care visits, along with the impact this has on diagnosis, and she provides tips for...
Andrea Russo, MD, director,...
11/10/2020
Pharmacy Learning Network
Exploring Prescribing Rates of Combination Therapy for BP Control
Videos
Exploring Prescribing Rates of Combination Therapy for BP Control
07/08/2020
Julie Johnson, PharmD, and Oyunbileg Magvanjav, MD, PhD, discuss the results of their recent study that explores the relationship between prescribing rates of guideline-recommended antihypertensive drug classes and blood pressure control.
Julie Johnson, PharmD, and Oyunbileg Magvanjav, MD, PhD, discuss the results of their recent study that explores the relationship between prescribing rates of guideline-recommended antihypertensive drug classes and blood pressure control.
Julie Johnson, PharmD, and...
07/08/2020
Pharmacy Learning Network
Association Between Blood Pressure Levels, Racial Disparities in Later-Life Cognitive Decline
Videos
Association Between Blood Pressure Levels, Racial Disparities in Later-Life Cognitive Decline
06/17/2020
Deborah Levine, MD, MPH, breaks down her recent study and explains why black individuals with a higher blood pressure level may be linked to racial disparities in cognitive decline.
Deborah Levine, MD, MPH, breaks down her recent study and explains why black individuals with a higher blood pressure level may be linked to racial disparities in cognitive decline.
Deborah Levine, MD, MPH, breaks...
06/17/2020
Pharmacy Learning Network
Is Warfarin Beneficial in Reducing Ischemic Stroke Incidence in Patients With AF, End-Stage Renal Disease?
Videos
Is Warfarin Beneficial in Reducing Ischemic Stroke Incidence in Patients With AF, End-Stage Renal Disease?
05/04/2020
Mandeep S Randhawa, MD, division of cardiology, Michigan State University, discusses his recent study and explains why warfarin provides no benefit for ischemic stroke incidence or mortality, as well as increase the risk of hemorrhagic...
Mandeep S Randhawa, MD, division of cardiology, Michigan State University, discusses his recent study and explains why warfarin provides no benefit for ischemic stroke incidence or mortality, as well as increase the risk of hemorrhagic...
Mandeep S Randhawa, MD, division...
05/04/2020
Pharmacy Learning Network
Videos
Acute Coronary Syndromes
06/25/2015
At a regional Pharmacy Learning Network meeting, Dr. Jean Nappi sat down with Dr. Randolph Fugit to discuss acute coronary syndromes.
At a regional Pharmacy Learning Network meeting, Dr. Jean Nappi sat down with Dr. Randolph Fugit to discuss acute coronary syndromes.
At a regional Pharmacy Learning...
06/25/2015
Pharmacy Learning Network

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement